TP53 and cancer: To investigate the molecular mechanism underlying ACP52C‐mediated induction of apoptosis through CP2c monomers, we conducted an analysis of changes in the expression of markers involved in p53‐ and CP2c‐centered signaling pathways in cancer cells treated with ACP52C.